Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Low-field MRI for Breast Cancer Screening

NCT: NCT05486520 · ENROLLING_BY_INVITATION

NCT IDNCT05486520
StatusENROLLING_BY_INVITATION
Start Date2022-09-01
Completion2026-10-01

Brief Summary

This research study wants to learn more about improving the attainable image quality for ultra-low field MRI of the breast using new data acquisition methods(also called MRI pulse sequences) and image reconstruction algorithms. For this pilot study, are testing a new method to image breast cancers at ultra-low magnetic field. The findings from this breast imaging technique will be compared with results obtained from standard mammograms, ultrasounds, MRIs, clinical examinations, and pathology evaluations, when available. The ultra-low field breast MRI performed for this study will be for research purposes and will not be used to guide clinical care.

Frequently Asked Questions

What is Low-field MRI for Breast Cancer Screening?

Low-field MRI for Breast Cancer Screening is a clinical trial registered under NCT05486520. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT05486520?

The current status of NCT05486520 (Low-field MRI for Breast Cancer Screening) is: ENROLLING_BY_INVITATION.

When did Low-field MRI for Breast Cancer Screening start?

Low-field MRI for Breast Cancer Screening started on 2022-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.